Hjem › Alzheimers sykdom › Michigan
Kliniske studier for Alzheimers sykdom i Michigan
15 studier for Alzheimers sykdom søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
RekruttererFase 4
Alder 50 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
RekruttererFase 1
Alder 50 til 85 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
Rekrutterer
Alder 70 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- og 5 flere
Rekrutterer
Alder 18 og eldre · Kvinner · Oppdatert 24. jul. 2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
RekruttererFase 3
Alder 55 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 45 til 85 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 60 til 90 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT06584357Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.